James Sawalla Guseh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Athletes | 11 | 2024 | 1162 | 1.160 |
Why?
|
Exercise | 11 | 2024 | 5954 | 1.140 |
Why?
|
Blood Proteins | 2 | 2020 | 1191 | 0.590 |
Why?
|
Oxygen Consumption | 6 | 2024 | 1883 | 0.570 |
Why?
|
Chest Pain | 1 | 2022 | 1101 | 0.510 |
Why?
|
Electrocardiography | 3 | 2024 | 6413 | 0.470 |
Why?
|
Exercise Test | 5 | 2024 | 2187 | 0.420 |
Why?
|
Embolism | 1 | 2015 | 401 | 0.380 |
Why?
|
Sports | 4 | 2024 | 703 | 0.360 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1550 | 0.350 |
Why?
|
Coronary Vessels | 2 | 2022 | 3124 | 0.300 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6569 | 0.300 |
Why?
|
Death, Sudden, Cardiac | 3 | 2024 | 1568 | 0.300 |
Why?
|
Proteomics | 1 | 2020 | 3914 | 0.270 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 665 | 0.260 |
Why?
|
Receptor, Notch1 | 1 | 2009 | 520 | 0.260 |
Why?
|
Truth Disclosure | 1 | 2009 | 433 | 0.250 |
Why?
|
Cytokines | 2 | 2023 | 7453 | 0.220 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15661 | 0.210 |
Why?
|
Heart Failure | 3 | 2024 | 11879 | 0.210 |
Why?
|
Boidae | 1 | 2022 | 14 | 0.200 |
Why?
|
Sports Medicine | 1 | 2024 | 239 | 0.190 |
Why?
|
Pulmonary Ventilation | 1 | 2023 | 375 | 0.180 |
Why?
|
Complement Factor D | 1 | 2019 | 67 | 0.170 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2023 | 484 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.170 |
Why?
|
Complement C3a | 1 | 2019 | 66 | 0.170 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.170 |
Why?
|
Social Support | 1 | 2009 | 2193 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Physical Conditioning, Animal | 1 | 2022 | 363 | 0.150 |
Why?
|
Football | 1 | 2024 | 506 | 0.150 |
Why?
|
Erythema Infectiosum | 1 | 2018 | 15 | 0.150 |
Why?
|
Physical Endurance | 1 | 2020 | 370 | 0.140 |
Why?
|
Internet | 1 | 2009 | 3112 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 849 | 0.140 |
Why?
|
American Heart Association | 1 | 2021 | 1051 | 0.130 |
Why?
|
Echocardiography | 4 | 2024 | 5047 | 0.130 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2018 | 147 | 0.130 |
Why?
|
Humans | 34 | 2024 | 768970 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3269 | 0.130 |
Why?
|
Ventricular Remodeling | 2 | 2021 | 1282 | 0.130 |
Why?
|
Muscle Development | 1 | 2017 | 258 | 0.130 |
Why?
|
Running | 1 | 2020 | 490 | 0.120 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11521 | 0.120 |
Why?
|
Cardiology | 2 | 2024 | 1701 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2024 | 1421 | 0.120 |
Why?
|
Cardiomegaly | 1 | 2017 | 591 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2020 | 741 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 1682 | 0.110 |
Why?
|
Ultrasonography, Interventional | 1 | 2022 | 1524 | 0.110 |
Why?
|
Lung | 2 | 2009 | 10099 | 0.110 |
Why?
|
Stroke Volume | 3 | 2023 | 5622 | 0.100 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1359 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 899 | 0.100 |
Why?
|
Aorta | 1 | 2020 | 2046 | 0.100 |
Why?
|
Male | 16 | 2024 | 365203 | 0.100 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2133 | 0.100 |
Why?
|
Heart Ventricles | 2 | 2021 | 3840 | 0.090 |
Why?
|
Adult | 12 | 2024 | 223851 | 0.090 |
Why?
|
Genetic Loci | 1 | 2020 | 2630 | 0.090 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 196 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3421 | 0.080 |
Why?
|
Self Disclosure | 1 | 2009 | 248 | 0.080 |
Why?
|
Anemia | 1 | 2018 | 1517 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9621 | 0.070 |
Why?
|
Metaplasia | 1 | 2009 | 326 | 0.070 |
Why?
|
Blood Pressure | 2 | 2021 | 8544 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2754 | 0.070 |
Why?
|
Exercise Tolerance | 2 | 2023 | 846 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3941 | 0.070 |
Why?
|
Endoderm | 1 | 2008 | 165 | 0.070 |
Why?
|
Female | 14 | 2024 | 397515 | 0.070 |
Why?
|
Mucus | 1 | 2009 | 346 | 0.070 |
Why?
|
Interleukin-13 | 1 | 2009 | 391 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2009 | 3702 | 0.070 |
Why?
|
Professional Competence | 1 | 2009 | 430 | 0.070 |
Why?
|
Middle Aged | 10 | 2024 | 223737 | 0.060 |
Why?
|
Mesoderm | 1 | 2008 | 679 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4447 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2008 | 725 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4541 | 0.050 |
Why?
|
Prognosis | 1 | 2024 | 30046 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1095 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Physician's Role | 1 | 2009 | 926 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1437 | 0.050 |
Why?
|
Eicosanoids | 1 | 2023 | 284 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11230 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2009 | 11684 | 0.050 |
Why?
|
Technology | 1 | 2023 | 296 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12801 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2022 | 180 | 0.040 |
Why?
|
Rodentia | 1 | 2022 | 262 | 0.040 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2022 | 241 | 0.040 |
Why?
|
Altitude | 1 | 2021 | 163 | 0.040 |
Why?
|
Glycoproteins | 1 | 2008 | 2202 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54962 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2024 | 421 | 0.040 |
Why?
|
Oxygen | 2 | 2022 | 4272 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 60131 | 0.040 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 124 | 0.040 |
Why?
|
Cell Lineage | 1 | 2008 | 2576 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13091 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 2018 | 42 | 0.040 |
Why?
|
Physical Fitness | 1 | 2022 | 744 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1136 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3612 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 939 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21547 | 0.030 |
Why?
|
Fetal Death | 1 | 2018 | 434 | 0.030 |
Why?
|
Models, Animal | 1 | 2022 | 2122 | 0.030 |
Why?
|
Dyspnea | 1 | 2023 | 1352 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4528 | 0.030 |
Why?
|
Risk Factors | 4 | 2024 | 74976 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12253 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1839 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3539 | 0.030 |
Why?
|
Viremia | 1 | 2018 | 725 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59739 | 0.030 |
Why?
|
Animals | 6 | 2022 | 169335 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1811 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 19023 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1313 | 0.030 |
Why?
|
Neural Pathways | 1 | 2024 | 3120 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2024 | 1886 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2018 | 863 | 0.030 |
Why?
|
Body Mass Index | 2 | 2020 | 13055 | 0.020 |
Why?
|
Mice | 4 | 2019 | 82072 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8749 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1389 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7885 | 0.020 |
Why?
|
Time Factors | 2 | 2024 | 40261 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1619 | 0.020 |
Why?
|
Headache | 1 | 2018 | 1264 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41808 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26395 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23653 | 0.020 |
Why?
|
Galactosides | 1 | 2008 | 54 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6673 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2008 | 168 | 0.020 |
Why?
|
Claudins | 1 | 2008 | 117 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3800 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171786 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2008 | 278 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2018 | 2190 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8384 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2019 | 3982 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10633 | 0.020 |
Why?
|
Integrases | 1 | 2008 | 520 | 0.020 |
Why?
|
Crohn Disease | 1 | 2018 | 2294 | 0.020 |
Why?
|
Insulin | 1 | 2019 | 6610 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1904 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14794 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2827 | 0.010 |
Why?
|
Epithelium | 1 | 2008 | 1607 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2008 | 1714 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81903 | 0.010 |
Why?
|
United States | 2 | 2021 | 73186 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13021 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15951 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2008 | 14484 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1493 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4592 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20776 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13510 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1836 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39394 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30265 | 0.010 |
Why?
|
Genotype | 1 | 2008 | 13048 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89244 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10486 | 0.010 |
Why?
|